Alexander Denner, senior managing director of Icahn Partners LP
(IEP) and a leading player in health care investments by firm
founder Carl Icahn, is considering leaving to start his own hedge
fund, Bloomberg News reported Thursday, citing two people with
knowledge of the plan.
Denner, 42 years old, would open his fund firm by the end of
this year, and Icahn might invest in it, one of the sources told
Bloomberg.
Icahn wasn't available to comment, the news service cited an
assistant to the famed activist investor as saying.
Since joining Icahn's New York firm in 2006, Denner has been
instrumental in management shuffles, efforts to boost sales or
restructurings of at least six pharmaceutical companies. He is
chairman of Enzon Pharmaceuticals Inc. (ENZN) and serves on the
boards of Biogen Idec Inc. (BIIB) and Amylin Pharmaceuticals Inc.
(AMLN).
An Icahn team led by Denner failed in August to win
representation on Forest Laboratories Inc.'s (FRX) board after the
drugmaker proposed three new directors of its own.
Full story at
http://www.bloomberg.com/news/2011-09-15/icahn-s-denner-said-to-consider-leaving-to-start-own-hedge-fund.html
-Dow Jones Newswires; 212-416-2900